Latest
news

LR Health & Beauty SE continues growth trajectory in the 2024 financial year

• Sales increased to EUR 289.2 million
• EBITDA reported at EUR 27.3 million, burdened by one-off extraordinary effects
• Career plan realignment leads to significant boost in new sales careers
• Successful launch of new LR Aloe Via Magic Power Duo skincare range contributes to positive business outlook in 2025
• 2025 forecast: significant increase in EBITDA with stable to moderate sales growth

Ahlen, 25 April 2025 – LR Health & Beauty SE, Europe’s leading digital social commerce company for high-quality nutritional supplements and beauty products, today published its final audited financial results for 2024. With this, the Group confirms the preliminary figures for the 2024 financial year announced on 28 February 2025, according to which LR Health & Beauty SE achieved sales (revenue from goods sold) of EUR 289.2 million (2023: EUR 276.5 million), representing a year-on-year increase in sales of 4.6%. This increase was significantly driven by the realignment of the career plan, on the one hand, and the successful launches of the colour cosmetics line LR ZEITGARD Signature, and the intestinal metabolism treatment LR HEALTH MISSION, on the other. The LR Group therefore achieved its sales forecast for 2024, which it had raised in November to a range of EUR 288 to 292 million.

Furthermore, LR Health & Beauty SE achieved an EBITDA reported of EUR 27.3 million in the 2024 financial year, compared to EUR 31.4 million in the previous year. This was in line with the forecast for EBITDA reported, which had been adjusted in November to a range of EUR 26 to 29 million. In the reporting period, earnings development was particularly impacted by one-off, extraordinary effects related to the realignment of the career plan in the fourth quarter and the early refinancing of the bond in spring 2024. Normalized EBITDA amounted to EUR 32.6 million in 2024 (2023: EUR 35.4 million).

Dr Andreas Laabs, Chief Executive Officer (CEO) of LR Health & Beauty SE, elaborates on the Group’s strategic initiatives: “In 2024, we consistently executed our strategy and took a major step toward long-term corporate success with the realignment of our career plan. This year, we are again seeing a strong increase in the number of new distributors who are using our onboarding programmes to launch their careers. By continuing to digitalise our business processes, we are empowering our partner community to grow their careers successfully. At the same time, we are expanding our digital offering – whether through training, information, or sales initiatives.” 

Innovative product launches drive new growth opportunities

In 2025, the LR Group will continue to focus on expanding and optimising its product portfolio. The new LR Aloe Via Magic Power Duo skincare range was successfully launched in April. This innovative skincare range features an even more powerful fermented aloe vera extract.

Valdemaras Gordinskis, the LR Group’s Vice President Global Controlling and Investor Relations, comments: “Processing aloe vera has always been one of LR’s core competencies. Now, with the unique combination of pure aloe vera leaf gel and fermented aloe vera, we have taken skincare a step further. With the patented Aloe Via Magic Power Duo product solution, we are setting new standards in skincare and expanding our range of health and beauty products. For LR, product innovation is an important pillar on the path to sustained profitable growth.”

Positive outlook for 2025

LR Health & Beauty SE is well positioned to take advantage of the attractive growth opportunities in the health & beauty sectors. Against a backdrop of high uncertainty in the market environment and continued consumer reticence, LR expects stable to moderately rising sales (revenue from goods sold) in the 2025 financial year, based on conservative assumptions. Furthermore, given the expected sales development, operational improvements and the absence of extraordinary effects compared to the previous year, the Group is expected to achieve a significant year-on-year increase in EBITDA. 

The full 2024 Annual Report is available from today on the company website at https://ir.lrworld.com/. At the end of May 2025, LR will also publish the 2024 Sustainability Report and make it available for download here.

LR Group
Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 

LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  

The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 

In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 

LR currently has around 1,200 employees and hundreds of thousands of registered community members.

Your Contacts:

PR Contact:
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com  
https://ir.lrworld.com/ 

IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE achieves significant sales growth in the final quarter of 2024 and meets the sales and earnings forecast for the full year 2024
8.0% increase in sales in Q4 2024 to EUR 76.5 million, confirming growth trend 
Full-year sales at EUR 289.2 million, up 4.6% y-o-y
EBITDA reported of EUR 8.3 million in Q4 2024 and EUR 27.3 million in FY 2024 due to one-off charges 
Realignment of career plan and successful product launches such as LR ZEITGARD Signature provide positive momentum in 2024 and beyond

Ahlen, 28 February 2025 - LR Health & Beauty SE, Europe’s leading digital social commerce company in the area of high-quality nutritional supplements and cosmetic products, today publishes its figures for the fourth quarter of 2024 as well as preliminary sales and earnings figures for the full year 2024.

LR Health & Beauty SE closed the 2024 financial year with significant sales growth in the fourth quarter, confirming the growth trend of the third quarter. In the fourth quarter of 2024, LR achieved sales (revenue from goods sold) of EUR 76.5 million (Q4 2023: EUR 70.9 million), representing growth of 8.0%. For the full year 2024, LR Health & Beauty SE reports sales of EUR 289.2 million, compared to EUR 276.5 million in the previous year. This corresponds to an increase of 4.6% and is in line with the LR Group’s 2024 sales forecast of EUR 288 to 292 million, which had been raised in November.

“LR Group’s strong growth is confirmation that we are on the right track with our strategy. The positive performance in the final quarter of 2024 is primarily the result of the realignment of the career plan and the successful market launch of further product innovations. We’re constantly working to create the best possible conditions for the business success of our partners, who participated with great enthusiasm in a wide range of kick-off events at the beginning of the year. With LR ZEITGARD Signature, we have perfectly complemented our portfolio in the area of colour cosmetics. We are confident that this solid foundation will enable us to continue our growth trajectory in the year of LR’s 40th anniversary,” says Dr. Andreas Laabs, CEO of LR Health & Beauty SE.

In the fourth quarter of 2024, LR Health & Beauty SE generated EBITDA reported of EUR 8.3 million (Q4 2023: EUR 9.0 million). On a preliminary basis, EBITDA reported for the full year 2024 reached EUR 27.3 million, compared to EUR 31.4 million in 2023 and was therefore in line with the forecast for EBITDA reported adjusted in November to EUR 26 to 29 million. In particular, one-off extraordinary effects related to the realignment of the career plan in the fourth quarter and the early refinancing of the bond in spring 2024 had a negative impact on the earnings development in the financial year. Normalized EBITDA decreased to EUR 9.5 million in the fourth quarter of 2024, compared to EUR 10.2 million in the fourth quarter of the previous year. In the full year 2024, normalized EBITDA reached EUR 32.6 million on a preliminary basis (2023: EUR 35.4 million).

Valdemaras Gordinskis, Vice President Global Controlling and Investor Relations at LR Health & Beauty SE, comments: “In 2025, we will continue to focus on implementing further strategic measures. For example, we are stepping up the development of new product innovations in order to expand our range of high-quality nutritional supplements and cosmetic products. We will also focus on increasing the efficiency and profitability of the LR Group through operational improvements in production and logistics as well as the further digitalization of our sales activities.”

The report for the fourth quarter of 2024 is available online from today on the company website at https://ir.lrworld.com/. The final, audited figures for the 2024 financial year will be published on the company website at the end of April 2025, together with the annual report. 

* As issuer of the New Bond 2024/2028, LR Health & Beauty SE publishes the figures for the fourth quarter and the full year 2024 and for the relevant periods in the previous year. The previous year’s figures for 2023 may differ from the figures for 2023 published previously by LR Global Holding GmbH.
 

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 
 
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  
 
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 
 
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 
 
LR currently has around 1,200 employees and hundreds of thousands of registered community members. 

Your Contacts: 
 
PR Contact:  
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication  
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com 
https://ir.lrworld.com/ 
 
 
IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de 

LR Health & Beauty SE publishes bond prospectus and applies for admission to trading of bonds on the corporate bond list of Nasdaq Stockholm

Ahlen, 26 February 2025 – On 4 March 2024, LR Health & Beauty SE (“LR SE”) issued senior secured floating rate bonds (2024/2028) in an amount of EUR 130,000,000 (the “Bonds”). Under the terms and conditions for the Bonds, LR SE has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For the purpose of the admission to trading, LR SE has prepared a listing prospectus which has been approved by the Swedish Financial Supervisory Authority today. LR SE will submit an application for admission to trading of the Bonds and the first trading day on Nasdaq Stockholm is expected to be on or about 28 February 2025. 

The prospectus will be available at LR Group’s website, ir.lrworld.com/en/bond/ and the Swedish Financial Supervisory Authority’s website www.fi.se. 

LR Group

Following the motto "More quality for your life" the LR Group with headquarters in Ahlen/Westphalia successfully produces and markets various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive social commerce company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool "LR neo" offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. 
 
LR has been firmly established on the market since 1985 as a "people business" company that focuses on people and personal advice. In times of changing working environments, the business model particularly appeals to those who are looking for more flexibility, a better work-life balance and greater financial independence.  
 
The processing of Aloe Vera has been one of the core competencies of LR for more than 20 years. Only the valuable inside of the leaf is used for the products. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. 
 
In autumn 2009, LR founded the LR Global Kids Fund e.V., which supports deprived children and their families in many countries around the world efficiently and unbureaucratically in cooperation with local institutions. For further information on our commitment to sustainability, please read our sustainability report. 
 
LR currently has around 1,200 employees and hundreds of thousands of registered community members. 

Your Contacts:

PR Contact:  
LR Health & Beauty SE  
Almut Kellermeyer   
Head of Corporate Communication  
Kruppstraße 55  
59227 Ahlen  
Phone: +49(0)2382 7813-106 
E-Mail: a.kellermeyer@LRworld.com 
https://ir.lrworld.com/ 

IR Contact: 
cometis AG 
Thorben Burbach 
Unter den Eichen 7 | Gebäude D 
65195 Wiesbaden 
Phone: +49(0)611 - 205855-23 
Fax: +49(0)611 - 205855-66 
E-Mail: burbach@cometis.de